Cargando…

Current therapies and future prospective for locally aggressive mesenchymal tumors

Locally aggressive mesenchymal tumors comprise a heterogeneous group of soft tissue and bone tumors with intermediate histology, incompletely understood biology, and highly variable natural history. Despite having a limited to absent ability to metastasize and excellent survival prognosis, locally a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maleddu, Alessandra, Zhu, Jessica, Clay, Michael Roy, Wilky, Breelyn Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401592/ https://www.ncbi.nlm.nih.gov/pubmed/37546427 http://dx.doi.org/10.3389/fonc.2023.1160239

Ejemplares similares

Emerging mechanisms of immunotherapy resistance in sarcomas
por: Florou, Vaia, et al.
Publicado: (2022)

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
por: Morandi, Andrea, et al.
Publicado: (2017)

LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt/β-Catenin Signaling
por: Scannell, Christopher A., et al.
Publicado: (2013)

Beyond Palliation: Therapeutic Applications of (153)Samarium-EDTMP
por: Wilky, Breelyn A., et al.
Publicado: (2013)

Atypical Teratoid Rhabdoid Tumor: Current Therapy and Future Directions
por: Ginn, Kevin F., et al.
Publicado: (2012)

Locally Advanced Cancer of the Esophagus, Current Treatment Strategies, and Future Directions
por: Rahma, Osama E., et al.
Publicado: (2012)

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
por: Chang, Ying-Jun, et al.
Publicado: (2021)

Ultrasound radiomics in personalized breast management: Current status and future prospects
por: Gu, Jionghui, et al.
Publicado: (2022)

A nonrandom association of sarcoidosis in patients with gastrointestinal stromal tumor and other sarcomas
por: Espejo, Andrea P, et al.
Publicado: (2018)

Primary Neuroendocrine Tumor of the Breast: Current Understanding and Future Perspectives
por: Sun, Hongna, et al.
Publicado: (2022)

Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective
por: Prisciandaro, Michele, et al.
Publicado: (2022)

Considerations for immunotherapy in patients with cancer and comorbid immune dysfunction
por: Florou, Vaia, et al.
Publicado: (2021)

Multidisciplinary team diagnosis and treatment of pancreatic cancer: Current landscape and future prospects
por: Yao, Weirong, et al.
Publicado: (2023)

Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2016)

Circulating Tumor Cells in Gastrointestinal Cancers: Current Status and Future Perspectives
por: Yang, Chaogang, et al.
Publicado: (2019)

High grade sarcoma presenting as multifocal recurrent seromas after inguinal hernia repair: A case report
por: Muir, Lorne D, et al.
Publicado: (2020)

The Implications of PDK1–4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance
por: Atas, Emine, et al.
Publicado: (2020)

Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
por: Peng, Yan, et al.
Publicado: (2021)

Current Options and Future Directions in Immune Therapy for Glioblastoma
por: Lynes, John, et al.
Publicado: (2018)

Editorial: Biology-Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future Challenges
por: Grünewald, Thomas G. P., et al.
Publicado: (2016)

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
por: Li, Ying, et al.
Publicado: (2023)

Nutritional Exchanges Within Tumor Microenvironment: Impact for Cancer Aggressiveness
por: Comito, Giuseppina, et al.
Publicado: (2020)

Concomitant Kinase-Dead BRAF and Oncogenic KRAS Lead to an Aggressive Biologic Behavior and Tumor Lysis Syndrome: A Case Report
por: Holland, Roy, et al.
Publicado: (2022)

The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting
por: Maleddu, Alessandra, et al.
Publicado: (2011)

Aggressive Local Treatment Improves Survival in Stage IV Breast Cancer With Synchronous Metastasis
por: Lian, Chen-Lu, et al.
Publicado: (2020)

Atezolizumab for the First-Line Treatment of Non-small Cell Lung Cancer (NSCLC): Current Status and Future Prospects
por: Ryu, Rachel, et al.
Publicado: (2018)

Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects
por: Guo, Bin, et al.
Publicado: (2023)

Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions
por: Merlini, Alessandra, et al.
Publicado: (2023)

Current and Future Treatment Strategies for Rhabdomyosarcoma
por: Chen, Celine, et al.
Publicado: (2019)

A rare highly aggressive tumor of the kidney: The pure epithelioid angiomyolipoma
por: Bani, Mohamed Amine, et al.
Publicado: (2018)

Microscopic Invasion of Nerve Is Associated With Aggressive Behaviors in Pancreatic Neuroendocrine Tumors
por: Zhou, Hao, et al.
Publicado: (2021)

Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects
por: Kuryk, Lukasz, et al.
Publicado: (2022)

Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future
por: Nicolini, Fabio, et al.
Publicado: (2020)

Pseudomonas aeruginosa in Cancer Therapy: Current Knowledge, Challenges and Future Perspectives
por: Pang, Zheng, et al.
Publicado: (2022)

Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2021)

Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers – current evidence and future directions
por: Lam, Rachel C. T., et al.
Publicado: (2022)

Current applications and future prospects of nanomaterials in tumor therapy
por: Huang, Yu, et al.
Publicado: (2017)

Rectal Tumor Stiffness Quantified by In Vivo Tomoelastography and Collagen Content Estimated by Histopathology Predict Tumor Aggressiveness
por: Hu, Jiaxi, et al.
Publicado: (2021)

Radiation Induced Metabolic Alterations Associate With Tumor Aggressiveness and Poor Outcome in Glioblastoma
por: Gupta, Kshama, et al.
Publicado: (2020)

The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype
por: Yu, Jing-Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nc6htk0g5jqh2v96av8kjq64qi